---
title: Codis vs Stason Industrial Corporation
slug_a: codis
slug_b: stasonpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/codis/stasonpharma
---

# Codis vs Stason Industrial Corporation

Side-by-side profile data from each company listing on this directory.

## Codis

- Profile: [/companies/codis](/companies/codis)

Codis — Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities.

Services: 8. Modalities: 1. Indications: 0. Locations: 5. Certifications: 2. The strongest documented coverage currently appears in services (8).

### Services

- Oral Solid Dosage Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Secondary Packaging & Labeling
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Oral Solid Dose (OSD)
- Max chemical: Commercial (>100 kg / tonne)

## Stason Industrial Corporation

- Profile: [/companies/stasonpharma](/companies/stasonpharma)

Stason Industrial Corporation — US-based CDMO offering contract packaging, analytical testing, and manufacturing services for clinical trial and commercial pharmaceutical production, with specialized high-containment capabilities for potent compounds.

Services: 10. Modalities: 1. Indications: 3. Locations: 2. Certifications: 1. The strongest documented coverage currently appears in services (10).

### Services

- Analytical Method Development & Validation
- ICH Stability Studies
- HPAPI Manufacturing (High-Potency)
- Sterile Fill-Finish & Aseptic Manufacturing
- Lyophilization (Freeze Drying)
- Oral Solid Dosage Manufacturing
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Secondary Packaging & Labeling

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Oral Solid Dose (OSD)
- Lyophilized Vials
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI